Human Genome Epidemiology Literature Finder
|
Records 1 - 17 (of 17 Records) |
| Query Trace: Multiple Myeloma and MTHFR[original query] |
|---|
| Normal frequencies of the C677T genotypes on the methylenetetrahydrofolate reductase (MTHFR) gene among lymphoproliferative disorders but not in multiple myeloma. Leukemia & lymphoma 2000 Nov 39 (5-6): 607-12. González Ordóñez A J, Fernández Carreira J M, Fernández Alvarez C R, Martin L, Sánchez Garcia J, Medina Rodríguez J M, Alvarez M V, Coto |
| Methylenetetrahydrofolate reductase genotype does not play a role in multiple myeloma pathogenesis. British journal of haematology 2002 Jun 117 (4): 890-2. González-Fraile Maria I, García-Sanz Ramo?, Mateos Maria V, Balanzategui Ana, González Marcos, Váquez Lourdes, San Miguel Jesús |
| Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. British journal of haematology 2003 Mar 120 (6): 1051-4. Lincz Lisa F, Scorgie Fiona E, Kerridge Ian, Potts Rachelle, Spencer Andrew, Enno Ar |
| Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myeloma. Annals of hematology 2006 Jul 85 (7): 474-7. Chiusolo Patrizia, Farina Giuliana, Putzulu Rossana, Reddiconto Giovanni, Fiorini Alessia, De Stefano Valerio, Rossi Elena, Palladino Mariangela, Leone Giuseppe, Sica Simo |
| MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea. Leukemia research 2007 Sep 31 (9): 1213-7. Moon Hee Won, Kim Tae Young, Oh Bo Ra, Min Hyun Chung, Cho Han Ik, Bang Soo Mee, Lee Jae Hoon, Yoon Sung Soo, Lee Dong So |
| Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leukemia research 2008 Mar 32 (3): 401-5. Lima Carmen S P, Ortega Manoela M, Ozelo Margareth C, Araujo Renato C, De Souza Cármino A, Lorand-Metze Irene, Annichino-Bizzacchi Joyce M, Costa Fernando |
| Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma. American journal of hematology 2007 Sep 82 (9): 798-801. Kim Hee Nam, Kim Yeo-Kyeoung, Lee Il-Kwon, Lee Je-Jung, Yang Deok-Hwan, Park Kyeong-Soo, Choi Jin-Su, Park Moo Rim, Jo Deog Yeon, Kim Hyeoung-Jo |
| [A new method for 5, 10-methylenetetrahydrofolate reductase single nucleotide polymorphisms genotyping used to study susceptibility of hematological malignancy]. Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2006 Dec 14 (6): 1069-73. Chen Bao-An, Jiang Ni, Ji Mei-Ju, Hou Peng, Lu Zu-Hong, Gao Chong, Ding Jia-Hua, Sun Yun-Yu, Wang Jun, Cheng Jian, Zhao Ga |
| The role of MTHFR gene in multiple myeloma. Journal of human genetics 2008 53 (6): 499-507. Zintzaras Elias, Giannouli Stavroula, Rodopoulou Paraskevi, Voulgarelis Micha |
| Study of specific genetic and epigenetic variables in multiple myeloma. Leukemia & lymphoma 2010 Dec 51 (12): 2270-4. Hatzimichael Eleftheria, Dasoula Aggeliki, Benetatos Leonidas, Syed Nelofer, Dranitsaris George, Crook Tim, Bourantas Konstantin |
| Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions. Annals of hematology 2011 Sep 90 (9): 1037-45. Benetatos Leonidas, Dasoula Aggeliki, Hatzimichael Eleftheria, Syed Nelofer, Voukelatou Maria, Dranitsaris George, Bourantas Konstantinos L, Crook T |
| The relationship between methylenetetrahydrofolate reductase polymorphism and hematological malignancy. Clinical laboratory 2014 60 (5): 767-74. Jiang Ni, Zhu Xishan, Zhang Hongmei, Wang Xiaoli, Zhou Xinna, Gu Jiezhun, Chen Baoan, Ren J |
| Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014 Apr 23 (4): 670-4. Martino Alessandro, Campa Daniele, Jurczyszyn Artur, Martínez-López Joaquín, Moreno María José, Varkonyi Judit, Dumontet Charles, García-Sanz Ramón, Gemignani Federica, Jamroziak Krzysztof, St?pie? Anna, Jacobsen Svend E Hove, Andersen Vibeke, Jurado Manuel, Landi Stefano, Rossi Anna Maria, Lesueur Fabienne, Marques Herlander, Dudzi?ski Marek, W?tek Marzena, Moreno Victor, Orciuolo Enrico, Petrini Mario, Reis Rui Manuel, Ríos Rafael, Sainz Juan, Vogel Ulla, Buda Gabriele, Vangsted Annette Juul, Canzian Federi |
| Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case-control studies. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jun . Xie Shu-Zhe, Liu Zhi-Zhong, Yu Jun-Hua, Liu Li, Wang Wei, Xie Dao-Lin, Qin Jiang- |
| Meta-analysis of the association of MTHFR polymorphisms with multiple myeloma risk. Scientific reports 2015 5 10735. Ma Li-Min, Ruan Lin-Hai, Yang Hai-Pi |
| A Mendelian Randomization Study of Plasma Homocysteine and Multiple Myeloma. Scientific reports 2016 04 6 25204. Xuan Yang, Li Xiao-Hong, Hu Zhong-Qian, Teng Zhi-Mei, Hu Dao-J |
| Genetic polymorphisms and multiple myeloma risk: a meta-analysis. Annals of hematology 2020 3 99 (5): 1017-1024. Zhang Pengcheng, Liu Bi |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 30, 2023
- Content source: